Common polymorphisms in ITGA2, PON1 and THBS2 are associated with coronary atherosclerosis in a candidate gene association study of the Chinese Han population

Journal of Human Genetics

Volumn 55, Issue 8, 2010, Pages 490-494

  Wang, Ying ^a,b   Fu, Wenqing ^c   Xie, Fang ^a,b   Wang, Yi ^b,c   Chu, Xun ^a,b   Wang, Haifeng ^b   Shen, Min ^b   Sun, Weiwei ^b   Lei, Rong ^a,b   Yang, Lin ^b   Wu, Hong ^d   Foo, Jianee ^e   Liu, Jianjun ^e   Jin, Li ^c   Huang, Wei ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b CHINESE NATIONAL HUMAN GENOME CENTER AT SHANGHAI   (China)

^c FUDAN UNIVERSITY   (China)

^d SECOND MILITARY MEDICAL UNIVERSITY   (China)

^e GENOME INSTITUTE OF SINGAPORE   (Singapore)

Author keywords

atherosclerosis; Chinese Han; coronary artery disease; ITGA2; PON1; THBS2

Indexed keywords

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; FEMALE; GENE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INFLAMMATION; ITGA2 GENE; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PHENOTYPE; PON1 GENE; POPULATION GENETICS; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; THBS2 GENE;

AGED; ARYLDIALKYLPHOSPHATASE; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HAPLOTYPES; HUMANS; INTEGRIN ALPHA2; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; THROMBOSPONDINS;

EID: 77957675702     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1038/jhg.2010.53     Document Type: Article

References (31)

1. WHO publishes definitive atlas on global heart disease and stroke epidemic. Indian J. Med. Sci 58, 405-406 (2004).
2. Reddy, K. S. Cardiovascular disease in non-Western countries. N. Engl. J. Med. 350, 2438-2440 (2004).
3. Mates, J. M., Perez-Gomez, C. & Nunez de Castro, I. Antioxidant enzymes and human diseases. Clin. Biochem. 32, 595-603 (1999).
4. Ross, R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340, 115-126 (1999).
5. Dzau, V. J., Braun-Dullaeus, R. C. & Sedding, D. G. Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat. Med. 8, 1249-1256 (2002).
6. Hansson, G. K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352, 1685-1695 (2005).
7. Libby, P. Inflammation in atherosclerosis. Nature 420, 868-874 (2002).
8. Lusis, A. J. Atherosclerosis. Nature 407, 233-241 (2000).
9. Wellcome Trust Case Control Consortium. Genome-wide association study of 14 000 cases of seven common diseases and 3000 shared controls. Nature 447, 661-678 (2007).
10. Arroyo-Espliguero, R., Avanzas, P., Jeffery, S. & Kaski, J. C. CD14 and toll-like receptor 4: a link between infection and acute coronary events? Heart 90, 983-988 (2004).
11. Edfeldt, K., Bennet, A. M., Eriksson, P., Frostegard, J., Wiman, B., Hamsten, A. et al. Association of hypo-responsive toll-like receptor 4 variants with risk of myocardial infarction. Eur. Heart J. 25, 1447-1453 (2004).
12. McDermott, D. H., Yang, Q., Kathiresan, S., Cupples, L. A., Massaro, J. M., Keaney, J. F. Jr et al. CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham. Heart Study Circ. 112, 1113-1120 (2005).
13. Zhang, X., Han, Y., Kang, J. & Yan, C. A monocyte chemoattractant protein-1 gene polymorphism is not associated with coronary artery disease in a Han Chinese population. Clin. Chim. Acta. 403, 241-243 (2009).
14. Carlson, C. S., Eberle, M. A., Rieder, M. J., Yi, Q., Kruglyak, L. & Nickerson, D. A. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am. J. Hum. Genet. 74, 106-120 (2004).
15. Hudson, R. R. Genetic Data Analysis. Methods for Discrete Population Genetic Data, Bruce S. Weir. Sinauer, Sunderland, MA, 1990. xiv, 377 pp., illus. $48; paper, $27. Science. 250, 575 (1990).
16. Barrett, J. C., Fry, B., Maller, J. & Daly, M. J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263-265 (2005).
17. Schaid, D. J., Rowland, C. M., Tines, D. E., Jacobson, R. M. & Poland, G. A. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am. J. Hum. Genet. 70, 425-434 (2002).
18. Chen, J., Zheng, H., Bei, J. X., Sun, L., Jia, W. H., Li, T. et al. Genetic structure of the Han Chinese population revealed by genome-wide SNP variation. Am. J. Hum. Genet. 85, 775-785 (2009).
19. Kritzik, M., Savage, B., Nugent, D. J., Santoso, S., Ruggeri, Z. M. & Kunicki, T. J. Nucleotide polymorphisms in the alpha 2 gene define multiple alleles that are associated with differences in platelet alpha 2beta 1 density. Blood 92, 2382-2388 (1998).
20. Ajzenberg, N., Berroeta, C., Philip, I., Grandchamp, B., Ducellier, P., Huart, V. et al. Association of the-92C/G and 807C/T polymorphisms of the {alpha}2 subunit gene with human platelets {alpha}2{beta}1 receptor density. Arterioscler. Thromb. Vasc. Biol. 25, 1756-1760 (2005).
21. Kostidou, E., Koliakos, G., Paletas, K. & Kaloyianni, M. Monocyte attachment and migration through collagen IV in diabetes mellitus. Mol. Cells 25, 452-456 (2008).
22. Serrato, M. & Marian, A. J. A variant of human paraoxonase/ arylesterase (HUMPONA) gene is a risk factor for coronary artery disease. J. Clin. Invest. 96, 3005-3008 (1995).
23. Christiansen, L., Bathum, L., Frederiksen, H. & Christensen, K. Paraoxonase 1 polymorphisms and survival. Eur. J. Hum. Genet. 12, 843-847 (2004).
24. Mackness, B., Davies, G. K., Turkie, W., Lee, E., Roberts, D. H., Hill, E. et al. Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype? Arterioscler. Thromb. Vasc. Biol. 21, 1451-1457 (2001).
25. Mackness, B., Durrington, P., McElduff, P., Yarnell, J., Azam, N., Watt, M. et al. Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study. Circulation 107, 2775-2779 (2003).
26. McCarthy, J. J., Parker, A., Salem, R., Moliterno, D. J., Wang, Q., Plow, E. F. et al. Large scale association analysis for identification of genes underlying premature coronary heart disease: cumulative perspective from analysis of 111 candidate genes. J. Med. Genet. 41, 334-341 (2004).
27. Boekholdt, S. M., Trip, M. D., Peters, R. J. G., Engelen, M., Boer, J. M. A., Feskens, E. J. M. et al. Thrombospondin-2 polymorphism is associated with a reduced risk of premature myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 22, e24-27 (2002).
28. Bornstein, P. Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1. J. Cell. Biol. 130, 503-506 (1995).
29. Yang, Z., Kyriakides, T. R. & Bornstein, P. Matricellular proteins as modulators of cellmatrix interactions: adhesive defect in thrombospondin 2-null fibroblasts is a consequence of increased levels of matrix metalloproteinase-2. Mol. Biol. Cell. 11, 3353-3364 (2000).
30. Noji, Y., Kajinami, K., Kawashiri, M. A., Todo, Y., Horita, T., Nohara, A. et al. Circulating matrix metalloproteinases and their inhibitors in premature coronary atherosclerosis. Clin. Chem. Lab. Med. 39, 380-384 (2001).
31. Kyriakides, T. R., Zhu, Y.-H., Smith, L. T., Bain, S. D., Yang, Z., Lin, M. T. et al. Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis. J. Cell Biol. 140, 419-430 (1998).